CNS-5161
CNS-5161 is an NMDA receptor antagonist which was under development for the treatment of neuropathic pain and cancer pain but was never marketed. It is taken by intravenously or transdermally.
CNS-5161 is an NMDA receptor antagonist which was under development for the treatment of neuropathic pain and cancer pain but was never marketed. It is taken by intravenously or transdermally.
CNS-5161 is an NMDA receptor antagonist which was under development for the treatment of neuropathic pain and cancer pain but was never marketed. It is taken by intravenously or transdermally.
Source: Wikipedia "CNS-5161" · CC BY-SA 4.0
Share this article: X · Bluesky